Evidence map›Paper›PMID 41884534›Full record

ArticleFrontiers in cellular and infection microbiology2026

Perillaldehyde combined with domiphen: synergistic bactericidal and anti-biofilm activity against

Jiaju Qiao, Shengmin Wu, Cuiyan Fu, Quanlin Zhao, Yang Gong, Linjie Xu, Dandan Tang, Yuan Gao, Wanyi Luo

Abstract read
In one paragraph

Article in Frontiers in cellular and infection microbiology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Jiaju Qiao *Department of Biotechnology, School of Life Sciences, Xuzhou Medical University, Xuzhou, China.
Shengmin Wu *Nanjing Institute of Environmental Sciences, Ministry of Ecology and Environment, Nanjing, Jiangsu, China.
Cuiyan FuDepartment of Biotechnology, School of Life Sciences, Xuzhou Medical University, Xuzhou, China.
Quanlin ZhaoDepartment of Biotechnology, School of Life Sciences, Xuzhou Medical University, Xuzhou, China.
Yang GongNanjing Institute of Environmental Sciences, Ministry of Ecology and Environment, Nanjing, Jiangsu, China.
Linjie XuDepartment of Biotechnology, School of Life Sciences, Xuzhou Medical University, Xuzhou, China.
Dandan TangDepartment of Biotechnology, School of Life Sciences, Xuzhou Medical University, Xuzhou, China.
Yuan GaoDepartment of Biotechnology, School of Life Sciences, Xuzhou Medical University, Xuzhou, China.
Wanyi LuoDepartment of Biotechnology, School of Life Sciences, Xuzhou Medical University, Xuzhou, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Introduction: Biofilms formed by pathogenic bacteria such as Methods: The antimicrobial activity of perillaldehyde and domiphen, alone and in combination, was assessed against Results: The combination of perillaldehyde and domiphen showed synergistic effects against both pathogenic strains, with a fractional inhibitory concentration index of less than 0.36. The combination of 1 μL/mL perillaldehyde and 1 μg/mL domiphen dispersed more than 53% of the biofilm mass in both Discussion: These results indicate that the novel combination of perillaldehyde and domiphen has the potential to decrease biofilm formation on various industrial material surfaces.

Indexed as

Anti-Bacterial AgentsBiofilmsEscherichia coliMonoterpenesStaphylococcus aureusAnimalsDrug SynergismLarvaMicrobial Sensitivity TestsMicrobial ViabilityStainless SteelAnti-Bacterial AgentsMonoterpenesStainless Steelbiofilmdrug combinationfoodborne pathogennatural productsynergistic effect

Identifiers

PMID41884534
PMCPMC13008891

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.